Home > News > Volunteer enrolments commence for Vivagel™ Phase 1 Study
November 12th, 2003
Volunteer enrolments commence for Vivagel™ Phase 1 Study
Abstract:
Starpharma Pooled Development Limited is pleased to announce that volunteer enrolment has now commenced for the VivaGel™ Phase I human safety study following receipt of final ethical approval from the Royal Adelaide Hospital Ethics Committee. This trial of VivaGel™ is creating a precedent as it is the first dendrimer nano-drug to advance to clinical trials under the FDA regulatory system.
Source:
Starpharma
Bookmark:
| Related News Press |
Nanomedicine
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||